Rise in the incidence of actinic keratosis has given way to desirable use of up-to-date therapeutics, which in turn has led to a steep increase in the number of impending drugs in pipeline.
Rise in the incidence of actinic keratosis has given way to desirable use of up-to-date therapeutics, which in turn has led to a steep increase in the number of impending drugs in pipeline. At the same time, there’s been a growing inclination toward adopting actinic keratosis treatment products among the geriatric race across the world. These factors have driven the growth of the actinic keratosis market in more than one way.
Also, wide availability of therapeutics has supplemented the market growth yet more. As for example, as per the Skin Cancer Foundation, one of the most common symptoms for malignancy is actinic keratosis and it happens to hit hard on more than fifty-eight million individuals in the United States. Simultaneously, as stated in the article issued in News Medical, the total rate of this skin disease in the United States is projected to be around ten percent in females and twenty-six percent in males.
According to Allied Market Research, the global actinic keratosis treatment market is anticipated to manifest a considerable CAGR from 2019 to 2026. Increasing cases of baldness, and issues such as skin wrinkling and sunburn patches have resulted into more cases of actinic keratosis. Especially, patients in regions such as New Zealand and Australia tend to reveal fairly more harmful upshots of sun exposure than in other provinces. And, naturally, the concerns related to the disease are taking a leap due to the rising patient base across the world.
Surge in the number of drug approvals and the launch of exclusive therapies for the disease have paved the way for lucrative opportunities in the industry. Late in 2020, Almirall, S.A. established the U.S. FDA consent and endorsement for tirbanibulin for the treatment of actinic keratosis in scalp and on face. Furthermore, in June, in the same year, Sun Pharmaceutical Industries Ltd. came up with Levulan Kerastick, a buzz worthy solution for the cure of minor to moderate cases of actinic keratosis of face, scalp, and other margins of the body.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/6354
Impact of COVID-19 on Actinic Keratosis Treatment Market-
Here, it’s worth stating that the outbreak of the Covid-19 pandemic led to several restrictions on non-emergent doctor visits along with complete lockdown in the majority of countries, thereby impacting the actinic keratosis treatment market negatively, especially during the initial period. For example, in 2019, there were almost 15.1 million treatments done for actinic keratosis alone in the United States, when in 2020, the number got declined to 12.7 million. However, the market has already started recouping fast.